Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$7,019,246
+$912,127 QoQ
Shares Held
27,894
-0.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#1,108
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cheviot Value Management, LLC holds $85,375,796 across 9 Drug Manufacturers - General names. ABBV ranks #4 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
154,695 | $39,287,889 | |
| 2 | MRK |
Merck & Co., Inc.
|
171,084 | $21,984,294 | |
| 3 | PFE |
Pfizer Inc
|
612,610 | $14,751,648 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
27,894 | $7,019,246 | |
| 5 | AMGN |
Amgen Inc
|
3,892 | $1,409,371 | |
| 6 | LLY |
ELI LILLY & Co
|
581 | $696,868 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,125 | $122,442 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
737 | $93,112 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,019,246 | 27,894 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $6,107,119 | 28,080 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $6,424,453 | 28,117 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $6,609,077 | 28,544 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $5,352,723 | 28,837 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,096,403 | 29,097 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $5,341,128 | 30,057 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,942,963 | 30,094 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,362,915 | 31,267 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $5,804,255 | 31,874 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $5,017,463 | 32,377 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,128,856 | 34,408 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $4,668,798 | 34,653 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $5,401,208 | 33,891 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,539,829 | 34,279 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,603,134 | 34,298 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,309,291 | 34,665 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $5,641,428 | 34,800 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,427,715 | 32,701 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,547,089 | 32,883 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,706,982 | 32,910 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,594,851 | 33,218 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $3,321,757 | 31,001 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,630,327 | 30,030 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,957,181 | 30,120 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $2,360,747 | 30,985 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||